: Pfizer’s $43 billion bid for Seagen aims to broaden company’s cancer portfolio

March 13, 2023

Pfizer’s PFE proposed acquisition of Seagen SGEN, which develops cancer treatments, for $43 billion indicates that the legacy drugmaker is focused on shoring up its oncology business.

Pfizer said Monday it plans to pay $229 per share in cash for Seagen, whose stock soared more than 15% in trading on Monday afternoon. Pfizer’s shares gained about 1.7%.

“[Seagen’s]…

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…